[an error occurred while processing this directive] | [an error occurred while processing this directive]
Effect and possible mechanism of BMI-1 gene on radiosensitivity of human pancreatic cancer SW1990 cell line
Wang Mincong1, Ma Hongbing1, Jin Yingying1, Han Lili2, Huang Lanxuan2, Xie Fei3
1Department of Radiotherapy, Second Affiliated Hospital, Medical School of Xi'an Jiao Tong University,Xi'an 710004, China; 2Department of Oncology, Second Affiliated Hospital, Medical School of Xi'an Jiao Tong University,Xi'an 710004, China; 3Xi'an Central Hospital, Xi'an Jiao Tong University,Xi'an 710003, China
AbstractObjective To evaluate the effect and possible mechanism of B-cell-specific moloney murine leukemia virus insertion site 1(BMI-1) on the radiosensitivity of pancreatic cancer SW1990 cell line. Methods According to our previous study results, 4Gy X-ray and down-regulation of BMI-1 expression were adopted as intervention conditions. The effect on the proliferation of SW1990 cells was assessed by clony formation assay. The effect on cell apoptosis and cell cycle was evaluated by flow cytometry. The effect upon the epithelial-mesenchymal transition (EMT) was determined by Western blot. Results Clony formation assay and flow cytometry found that the lowest cell proliferation ability and the highest apoptotic rate were obtained after BMI-1 down-regulation and 4Gy X-ray compared with other groups (all P<0.05). Flow cytometry revealed that the proportion of G0/G1 phase was significantly decreased, whereas the G2/M phase was remarkably increased in pancreatic cancer stem cells treated with 4Gy X-ray compared with the control group (both P<0.05). Nevertheless,opposite results were obtained after down-regulation of BMI-1 expression. Western blot showed that the expression of E-cadherin was up-regulated, whereas that of Vimentin was down-regulated following 4Gy X-ray (both P<0.05). Conclusion Downregulation of BMI-1 expression can enhance the radiosensitivity of pancreatic cancer SW1990 cells, and its mechanism may be related to cell cycle and EMT.
Fund:The Special Research Fund for Talent Training of The Second Affiliated Hospital of Xi'an Jiao Tong University[RC (XM)201706]
Cite this article:
Wang Mincong,Ma Hongbing,Jin Yingying et al. Effect and possible mechanism of BMI-1 gene on radiosensitivity of human pancreatic cancer SW1990 cell line[J]. Chinese Journal of Radiation Oncology, 2020, 29(7): 574-577.
Wang Mincong,Ma Hongbing,Jin Yingying et al. Effect and possible mechanism of BMI-1 gene on radiosensitivity of human pancreatic cancer SW1990 cell line[J]. Chinese Journal of Radiation Oncology, 2020, 29(7): 574-577.
[1] Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018[J]. CA Cancer J Clin, 2018, 68(1):7-30. DOI:10.3322/caac.21442. [2] Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016, 66(2):115-132. DOI:10.3322/caac.21338. [3] Stathis A, Moore MJ. Advanced pancreatic carcinoma:current treatment and future challenges[J]. Nat Rev Clin Oncol, 2010, 7(3):163-172. DOI:10.1038/nrclinonc.2009.236. [4] Biehs B, Hu JK, Strauli NB, et al. BMI1 represses Ink4a/Arf and Hox genes to regulate stem cells in the rodent incisor[J]. Nat Cell Biol, 2013, 15(7):846-852. DOI:10.1038/ncb2766. [5] Wang MC, Jiao M, Wu T, et al. Polycomb complex protein BMI-1 promotes invasion and metastasis of pancreatic cancer stem cells by activating PI3K/AKT signaling, an ex vivo, in vitro, and in vivo study[J]. Oncotarget, 2016, 7(8):9586-9599. DOI:10.18632/oncotarget.7078. [6] Min C, Wang CL, Jie C, et al. BMI-1, a promising therapeutic target for human cancer[J]. Oncol Lett, 2015, 10(2):583-588. DOI:10.3892/ol.2015.3361. [7] Phillips TM, McBride WH, Pajonk F. The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation[J]. J Nat Cancer Inst, 2006, 98(24):1777-1785. DOI:10.1093/jnci/djj495. [8] Piao LS, Hur W, Kim TK, et al. CD133+ liver cancer stem cells modulate radioresistance in human hepatocellular carcinoma[J]. Cancer Lett, 2012, 315(2):129-137. DOI:10.1016/j.canlet.2011.10.012. [9] Gomez-Casal R, Bhattacharya C, Ganesh N, et al. Non-small cell lung cancer cells survived ionizing radiation treatment display cancer stem cell and epithelial-mesenchymal transition phenotypes[J]. Mol Cancer, 2013, 12(1):94. DOI:10.1186/1476-4598-12-94. [10] Chi HC, Tsai CY, Tsai MM, et al. Roles of long noncoding rnas in recurrence and metastasis of radiotherapy-resistant cancer stem cells[J]. Int J Mol Sci, 2017, 18(9):1903. DOI:10.3390/ijms18091903. [11] Chen YC, Chang CJ, Hsu HS, et al. Inhibition of tumorigenicity and enhancement of radiochemosensitivity in head and neck squamous cell cancer-derived ALDH1-positive cells by knockdown of BMI-1[J]. Oral Oncol, 2010, 46(3):158-165. DOI:10.1016/j.oraloncology.2009.11.007. [12] Xu XH, Liu XY, Su J, et al. shRNA targeting Bmi-1 sensitizes CD44+ nasopharyngeal cancer stem-like cells to radiotherapy[J]. Oncol Rep, 2014, 32(2):764-770. DOI:10.3892/or.2014.3267. [13] Xu LH, Lyu X, Liu Y, et al. Knockdown of the Bmi-1 oncogene inhibits cell proliferation and induces cell apoptosis and is involved in the decrease of Akt phosphorylation in the human breast carcinoma cell line MCF-7[J]. Oncol Rep, 2011, 25(2):409-418. DOI:10.3892/or.2010.1078. [14] Desai BA, Bukhari AB, De A, et al. α-actinin-4 confers radioresistance coupled invasiveness in breast cancer cells through AKT pathway[J]. Biochim Biophys Acta Mol Cell Res, 2018, 1865(1):196-208. DOI:10.1016/j.bbamcr.2017.10.006. [15] Du B, Shim JS. Targeting epithelial-mesenchymal transition (EMT) to overcome drug resistance in cancer[J]. Molecules, 2016, 21(7):965. DOI:10.3390/molecules21070965.
2020, Vol. 29 
